Quick Answer
ABEONA THERAPEUTICS INC. reported Operating Income of -$89.45 million for fiscal year 2025.
ABEONA THERAPEUTICS INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$89.45M | -39.3% |
| 2024 | -$64.21M | -36.2% |
| 2023 | -$47.13M | +7.4% |
| 2022 | -$50.91M | +43.3% |
| 2021 | -$89.84M | -10.3% |
| 2020 | -$81.42M | -5.6% |
| 2019 | -$77.09M | -32.5% |
| 2018 | -$58.17M | -109.0% |
| 2017 | -$27.84M | -16.6% |
| 2016 | -$23.88M | -28.8% |
| 2015 | -$18.55M | -492.3% |
| 2014 | -$3.13M | +17.7% |
| 2013 | -$3.80M | +11.9% |
| 2012 | -$4.32M | +45.2% |
| 2011 | -$7.88M | -1.5% |
| 2010 | -$7.76M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$24.02M | -56.5% | -5.4% |
| June 30, 2025 | -$22.79M | -27.6% | -15.5% |
| March 31, 2025 | -$19.73M | -37.7% | -28.6% |
| September 30, 2024 | -$15.35M | -35.4% | +14.1% |
| June 30, 2024 | -$17.86M | -69.3% | -24.7% |
| March 31, 2024 | -$14.33M | -19.0% | -26.4% |
| September 30, 2023 | -$11.33M | -20.8% | -7.4% |
| June 30, 2023 | -$10.55M | -31.8% | +12.3% |
- ABEONA THERAPEUTICS INC. showed a decrease of -39.3% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, ABEONA THERAPEUTICS INC.’s operating income has declined by 1053.1% (from -$7.76 million to -$89.45 million).
- The most recent figure is from ABEONA THERAPEUTICS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: